Adipose-Derived Stem Cells Support Lymphangiogenic Parameters In Vitro.

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Secondary lymphedema is a common complication following cancer treatments like axillary lymph node dissection.
• Current therapies for lymphedema are primarily symptomatic and do not address the underlying lymphatic and adipose tissue loss.
• Tissue engineering presents a novel strategy to reconstruct functional adipose tissue with an integrated lymphatic network.

Purpose of the Study:

• To investigate the effects of adipose-derived stem cells (ASCs) on lymphatic endothelial cells (LECs) in vitro.
• To evaluate the impact of ASCs on LEC gene expression, proliferation, migration, and tube formation.
• To explore the potential of ASC-LEC co-culture for lymphedema tissue engineering therapies.

Main Methods:

• Co-culture experiments were performed using human ASCs and human LECs, both directly and indirectly.
• The role of recombinant vascular endothelial growth factor C (VEGF-C) was assessed in co-cultures.
• Lymphatic marker gene expression, cell proliferation, migration, and tube formation were analyzed.
• Immunomagnetic separation using CD31 magnetic beads was employed for direct co-culture analysis.

Main Results:

• Direct and indirect co-culture of ASCs significantly induced mRNA expression of lymphatic marker genes in LECs.
• ASCs promoted proliferation and migration of LECs in both direct and indirect co-culture settings.
• Co-culture with ASCs did not adversely affect the tube formation capacity of LECs.
• VEGF-C's specific role was investigated in conjunction with ASC-LEC interactions.

Conclusions:

• Co-culture of ASCs with LECs demonstrates a promising approach for lymphatic tissue regeneration.
• This cell-based therapy holds potential for developing effective treatments for secondary lymphedema.
• ASC-LEC co-culture could be a key component in future tissue engineering strategies for lymphatic reconstruction.